How Psychedelic Drugs Are Making a Comeback to Treat Depression

The hallucinogenic compound psilocybin is undergoing a renaissance-not as a recreational drug but as a potential treatment for mental health conditions. We follow the journey of one participant of a scientific study into the psychedelic drug's effect on depression. Learn more about your ad choices. Visit megaphone.fm/adchoices

Om Podcasten

WSJ’s Bold Names brings you conversations with the leaders of the bold-named companies featured in the pages of The Wall Street Journal. Hosts Tim Higgins and Christopher Mims speak to CEOs and business leaders in interviews that challenge conventional wisdom and take you inside the decisions being made in the C-suite and beyond.